| Financial Year |
March 31 2023 |
| Monetary Funds |
69,508,783.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
211,301,239.74 |
| Advances to Suppliers |
168,716,522.92 |
| Other Receivables |
11,741,976.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
208,640,338.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,718,024.00 |
| Total Current Assets |
677,626,885.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,617,004.54 |
| Fixed Assetes |
51,362,505.21 |
| Under-construction Projects |
6,705,399.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
250,206,106.87 |
| R&D expenses |
-- |
| Goodwill |
126,843,806.78 |
| Long-Term Deferred and Prepaid Expenses |
17,443,947.58 |
| Deferred Income Tax Assets |
39,554,603.55 |
| Other Non-Current Assets |
4,467,734.91 |
| Sub-Total of Non-Current Assets |
586,774,141.17 |
| Total Assets |
1,264,401,026.81 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
202,998,342.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,927,595.68 |
| Taxes Payable |
10,857,342.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,711,106.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,133,578.54 |
| Other Current Liabilities |
13,183,435.45 |
| Sub-Total of Current Liabilities |
435,594,610.46 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,582,056.80 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
55,454,382.19 |
| Total Liabilities |
491,048,992.65 |
| Paid-In Capital(Or Share Stock) |
170,990,043.00 |
| Capital Surplus |
274,375,676.44 |
| Surplus Reserve |
27,070,859.01 |
| LESS:Treasury Stock |
7,251,810.50 |
| Undistributed Profits |
308,167,266.21 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
773,352,034.16 |
| Owner's Equity（Stockholder's Equity） |
773,352,034.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,264,401,026.81 |
